Assessment of Cardiovascular Side Effects of Therapeutic Doses of Tricyclic Anti‐depressant Drugs
- 1 February 1975
- journal article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 5 (1) , 7-11
- https://doi.org/10.1111/j.1445-5994.1975.tb03247.x
Abstract
An assessment of the side effects of therapeutic doses of tricyclic anti-depressant drugs was attempted in 32 patients with depressive illness. The patients studied had no evidence of clinical heart disease or hypertension and were not receiving any other drugs. Moderate increase in heart rate and mild prolongation of atrioventricular conduction occurred. No significant effect on the corrected QT interval or blood pressure was found. There was no correlation between the increased heart rate, prolongation of the atrioventricular conduction time (PR interval) and plasma nortriptyline levels measured in 20 out of 32 patients.Keywords
This publication has 17 references indexed in Scilit:
- CARDIOTOXICITY OF AMITRIPTYLINEThe Lancet, 1972
- AMITRIPTYLINE POISONINGThe Lancet, 1965
- AMITRIPTYLINE AND IMIPRAMINE POISONINGThe Lancet, 1965
- AMITRIPTYLINE POISONINGThe Lancet, 1965
- AMITRIPTYLINE POISONINGThe Lancet, 1965
- AMITRIPTYLINE POISONINGThe Lancet, 1965
- Seven fatal cases involving imipramine in manJournal of Pharmacy and Pharmacology, 1964
- Imipramine Poisoning in ChildhoodBMJ, 1963
- ELECTROCARDIOGRAPHIC CHANGES DURING TREATMENT WITH LITHIUM AND WITH DRUGS OF THE IMIPRAMINE‐TYPE1Acta Psychiatrica Scandinavica, 1963
- CARDIAC COMPLICATIONS DURING TREATMENT WITH IMIPRAMIN (TOFRANIL)Acta Psychiatrica Scandinavica, 1961